Tigermed To Provide Merck Clinical Trial Services In China
This article was originally published in PharmAsia News
Executive Summary
Hangzhou Tigermed Consulting Co. Ltd. has signed a letter of intent with Merck & Co. Inc. to provide Merck with clinical trial services in China.